Ahmad Ali, Reha Jeffrey, Saied Abdul, Espat N Joseph, Somasundar Ponnandai, Katz Steven C
Division of Surgical Oncology, Roger Williams Medical Center, Providence, RI 02908, USA.
Department of Surgery, Boston University School of Medicine, Boston, MA, USA.
Hepatobiliary Surg Nutr. 2017 Jun;6(3):154-161. doi: 10.21037/hbsn.2016.08.08.
The primary objective of our study was to assess the association of primary tumor lymph node ratio (LNR) in stage IV colorectal adenocarcinomas (CRC) with overall survival (OS) and the extent of metastatic disease in the liver.
We analyzed data on 53 stage IV CRC patients who underwent surgical resection of the primary tumor. The median LNR of 0.25 was used to stratify patients into high LNR (H-LNR) and low LNR (L-LNR) groups. Statistical comparison was performed using chi square test and multiple regression models. OS was calculated using the Kaplan-Meier (KM) method while cox regression was used for multivariate analysis.
H-LNR status was associated with the presence of >3 liver metastases (LM) [odds ratio (OR): 2.43, P=0.047] and bilobar LM (OR: 3.94, P=0.039). The OS in H-LNR patients was significantly worse in the entire cohort compared to L-LNR (9% 34% at 3 years, P=0.027). The 5-year OS in patients undergoing liver resection for LM was also significantly worse in the H-LNR group (0% 37%, P=0.013). LNR was independently associated with survival on multivariate analysis [HR: 2.63; 95% confidence intervals (CI), 1.13-6.14; P=0.025].
In stage IV CRC, LNR is associated with the extent of hepatic tumor burden and was an independent predictor of survival in patients undergoing liver resection.
我们研究的主要目的是评估IV期结直肠癌(CRC)的原发肿瘤淋巴结比率(LNR)与总生存期(OS)以及肝脏转移疾病范围之间的关联。
我们分析了53例接受原发肿瘤手术切除的IV期CRC患者的数据。以中位数LNR 0.25将患者分为高LNR(H-LNR)组和低LNR(L-LNR)组。使用卡方检验和多元回归模型进行统计学比较。采用Kaplan-Meier(KM)法计算OS,采用cox回归进行多变量分析。
H-LNR状态与存在>3个肝转移(LM)[比值比(OR):2.43,P = 0.047]和双侧LM(OR:3.94,P = 0.039)相关。与L-LNR组相比,整个队列中H-LNR患者的OS明显更差(3年时为9%对34%,P = 0.027)。在接受LM肝切除的患者中,H-LNR组的5年OS也明显更差(0%对37%,P = 0.013)。多变量分析显示LNR与生存独立相关[风险比(HR):2.63;95%置信区间(CI),1.13 - 6.14;P = 0.025]。
在IV期CRC中,LNR与肝肿瘤负荷范围相关,并且是接受肝切除患者生存的独立预测因素。